PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

Bill on penalties for “medication intoxication” while driving passes first reading

On Tuesday, the State Duma passed in the first reading a government-sponsored bill introducing administrative liability for drivers who operate vehicles under the influence of certain medications.

Bill No. 379447-8 proposes amendments to Articles 12.8 and 12.27 (Part 3) of the Russian Code of Administrative Offenses (KoAP), expanding the scope of punishable intoxication. Under the draft, drivers would be held administratively liable not only for alcohol or drug intoxication, but also in cases where medical examinations detect the presence of substances (or groups of substances) from medications that impair attention and reaction, even if these substances are not classified as alcohol, narcotics, psychotropics, their analogues, or other new potentially hazardous psychoactive substances. Liability would apply if a combination of clinical signs of intoxication is observed due to such substances.

These amendments aim to make “medication intoxication” punishable under administrative law.

Currently, the absence of a rule in the KoAP allowing for penalties against drivers impaired by certain medications complicates efforts to ensure road safety, according to the explanatory note.

A list of relevant medications will be defined by a government decree. It may include anesthetics, anti-epileptic drugs, sleeping pills, sedatives, and others.

The procedure for medical examination to determine intoxication will be amended with a new section that establishes rules for detecting impairment caused by medications that reduce a driver’s ability to react.

Source: Interfax, May 16, 2025

Current news

  • March 10, 2026

    Public Procurement of Medicines in Russia Reached 1 Trillion Rubles in 2025

    Public procurement of medicines in Russia totaled 1 trillion rubles in 2025, representing a 26%…

  • March 10, 2026

    Retail Pharmaceutical Market Value Increased by 13.3% in 2025

    The value of Russia’s retail pharmaceutical market reached 1.83 trillion rubles in 2025, marking a…

  • March 10, 2026

    New Molecules Synthesized in Russia for Next-Generation Medicines

    The compounds could help develop antimicrobial, anticancer, and anti-inflammatory drugs, according to the press service…

  • March 10, 2026

    DSM Group Presents Top 10 Russian Pharmaceutical Distributors

    According to data from DSM Group, the pharmaceutical market volume at distributor prices reached 2.87…

  • March 10, 2026

    Russia Plans to Halve Dependence on Imports of Critical Biocomponents by 2030

    The strategy for developing the bioeconomy sector предусматривает создание новых рынков, включая синтетическую биологию, промышленную…

LLC “BioJet”. all rights reserved

  • Legal information